FindTrial
Sign In

Clinical study for cardiac MRI in evaluating early myocardial lesions in patients with muscular dystrophy

Clinical study for cardiac MRI in evaluating early myocardial lesions in patients with muscular dystrophy

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800018340
Enrollment
Unknown
Registered
2018-09-12
Start date
2018-09-12
Completion date
Unknown
Last updated
2021-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Muscular dystrophy

Interventions

Gold Standard:Genomic sequencing, muscle biopsy
Index test:Myocardial&#32
strain,&#32
T1/T2mapping&#32
value,&#32
late&#32
delayed&#32
enhancement&#32
(LGE),&#32
myocardial&#32
first&#32
pass&#32
perfusion

Sponsors

Department of Radiology, West China Second Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
4 Years to 18 Years

Inclusion criteria

Inclusion criteria: patients Diagnosed with muscular dystrophy by genome sequencing, muscle biopsy, and clinically relevant symptoms.

Exclusion criteria

Exclusion criteria: MRI examination contraindications, claustrophobia, contrast allergy, severe renal insufficiency (serum creatinine clearance >120 mmol/L), severe cardiac insufficiency (NYHA-IV grade), frequent atrial fibrillation, thyroid dysfunction.

Design outcomes

Primary

MeasureTime frame
Myocardial delayed enhancement;Myocardial tissue stress;Myocardial perfusion;—

Countries

China

Contacts

Public ContactYingkun Guo

Department of Radiology, West China Second Hospital, Sichuan University

gykpanda@163.com+86 18980006572

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026